Cargando…

Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinom (AC) is the most common form of lung cancer. Currently, the number of medical options to deal with lung cancer is very limited. In this study, we aimed to investigate potential therapeutic compounds for lung adenocarcinoma based on integrative analysis. METHODOLOGY/PRI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Guiping, Ye, Yun, Yang, Xiaoqin, Liao, Hongying, Zhao, Canguo, Liang, Shuang
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024967/ https://www.ncbi.nlm.nih.gov/pubmed/21283735 http://dx.doi.org/10.1371/journal.pone.0014573

Ejemplares similares

Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma
por: Liu, Xinyan, et al.
Publicado: (2015)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022)

Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma
por: Hu, Weilei, et al.
Publicado: (2020)

In Silico screening for functional candidates amongst hypothetical proteins
por: Desler, Claus, et al.
Publicado: (2009)

Screening of Multitarget-Directed Natural Compounds as Drug Candidates for Alzheimer’s Disease Using In Silico Techniques: Their Extraction and In Vitro Validation
por: Srivastava, Sukriti, et al.
Publicado: (2023)

In vivo and in silico screening for antimicrobial compounds from cyanobacteria
por: Strieth, Dorina, et al.
Publicado: (2022)

Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database
por: Shen, Youfeng, et al.
Publicado: (2022)

In silico high-throughput screening system for AKT1 activators with therapeutic applications in sepsis acute lung injury
por: Wang, Ziyi, et al.
Publicado: (2022)

In Silico Screening for Pesticide Candidates against the Desert Locust Schistocerca gregaria
por: Jackson, Graham E., et al.
Publicado: (2022)

Eosinophil peroxidase over-expression predicts the clinical outcome of patients with primary lung adenocarcinoma
por: Ye, Liang, et al.
Publicado: (2019)

In Silico Screening of Synthetic and Natural Compounds to Inhibit the Binding Capacity of Heavy Metal Compounds against EGFR Protein of Lung Cancer
por: Ayaz, Zainab, et al.
Publicado: (2022)

Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine
por: Ruan, Xinjia, et al.
Publicado: (2022)

In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidates
por: Singh, Raghvendra, et al.
Publicado: (2016)

In silico screening for candidate chassis strains of free fatty acid-producing cyanobacteria
por: Motwalli, Olaa, et al.
Publicado: (2017)

In Silico Screening of Quorum Sensing Inhibitor Candidates Obtained by Chemical Similarity Search
por: Shekarappa, Sharath Belenahalli, et al.
Publicado: (2022)

Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing
por: Jia, Meng, et al.
Publicado: (2023)

Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2
por: Zhao, Yong, et al.
Publicado: (2021)

Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
por: Daugaard, Iben, et al.
Publicado: (2016)

Synthesis and in silico screening of a library of β-carboline-containing compounds
por: Brummond, Kay M, et al.
Publicado: (2012)

Nontargeted Metabolomics for Phenolic and Polyhydroxy Compounds Profile of Pepper (Piper nigrum L.) Products Based on LC-MS/MS Analysis
por: Gu, Fenglin, et al.
Publicado: (2018)

In Silico Study of Cucurbita maxima Compounds as Potential Therapeutics Against Schistosomiasis
por: Mtemeli, Floryn Lynorah, et al.
Publicado: (2022)

Identification of Candidate Vaccine Antigens In Silico
por: Flower, Darren R., et al.
Publicado: (2012)

Identifying candidate agents for lung adenocarcinoma by walking the human interactome
por: Sun, Yajiao, et al.
Publicado: (2016)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics
por: Cullum, Richard L., et al.
Publicado: (2020)

Characterization of TIM-3 Expression and Its Correlation with TNF-α and IFN-γ in Patients with Surgically Resected Lung Adenocarcinoma
por: Tan, Jian, et al.
Publicado: (2023)

In Silico Screening of Antibacterial Compounds from Herbal Sources Against Vibrio cholerae
por: Perveen, Sabah, et al.
Publicado: (2015)

In Vitro Screening to Identify Anti-Toxoplasma Compounds and In Silico Modeling for Bioactivities and Toxicity
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2019)

First In Silico Screening of Insect Molecules for Identification of Novel Anti-Parasitic Compounds
por: Gallinger, Tom L., et al.
Publicado: (2022)

Exploring the Drug Potential of Phytochemicals as a Novel Therapeutic Drug Candidate for Herpesvirus: An In-silico Evaluation
por: Rani, A. Christy, et al.
Publicado: (2022)

Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs
por: Liang, Pengchen, et al.
Publicado: (2022)

Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma
por: Chen, Shengsong, et al.
Publicado: (2020)

Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for in vivo screening of candidate therapeutic compounds
por: Tseng, Wei-Chia, et al.
Publicado: (2018)

Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma
por: Polewko-Klim, Aneta, et al.
Publicado: (2022)

RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
por: Glaß, Markus, et al.
Publicado: (2020)

Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma
por: Guo, Tingting, et al.
Publicado: (2019)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

Comparative Gene Expression Profiling of Benign and Malignant Lesions Reveals Candidate Therapeutic Compounds for Leiomyosarcoma
por: Edris, Badreddin, et al.
Publicado: (2012)

Therapeutic Effect of Repurposed Temsirolimus in Lung Adenocarcinoma Model
por: Chang, Hsuen-Wen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0kqtlg4laaqhml8tu8d9os58tg